Published in JAMA on March 27, 2002
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension (2009) 2.99
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol (2009) 1.95
Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol (2010) 1.81
Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg (2003) 1.77
Long-term outcome of chronic dialysis in children. Pediatr Nephrol (2008) 1.72
Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.72
Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int (2007) 1.54
Phosphate control in end-stage renal disease: barriers and opportunities. Nephrol Dial Transplant (2013) 1.46
Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis (2009) 1.39
Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging. Eur Heart J (2013) 1.39
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis (2007) 1.32
Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2011) 1.30
Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol (2013) 1.23
Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens (2010) 1.22
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging (2012) 1.16
Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.13
Phosphate and cardiovascular disease. Adv Chronic Kidney Dis (2011) 1.06
Cystatin C associates with arterial stiffness in older adults. J Am Soc Nephrol (2009) 1.05
Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension (2009) 1.02
Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study. Clin J Am Soc Nephrol (2012) 1.02
Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. J Hum Hypertens (2010) 0.96
Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol (2008) 0.96
Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients. PLoS One (2012) 0.95
Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag (2005) 0.92
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. Kidney Int (2009) 0.90
A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient. Patient Prefer Adherence (2008) 0.89
Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol (2015) 0.87
Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Am J Kidney Dis (2009) 0.86
Intradialytic versus home-based exercise training in hemodialysis patients: a randomised controlled trial. BMC Nephrol (2009) 0.86
Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients. Clin J Am Soc Nephrol (2010) 0.84
Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis. Clin Exp Nephrol (2012) 0.84
Nutritional Intake in Adult Hemodialysis Patients. Top Clin Nutr (2011) 0.82
One year clinical outcomes of renal artery stenting: the results of ODORI Registry. Cardiovasc Intervent Radiol (2009) 0.80
Measures of blood pressure and cognition in dialysis patients. Hemodial Int (2012) 0.80
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR. Nephrol Dial Transplant (2012) 0.80
Pulse pressure and long-term survival after coronary artery bypass graft surgery. Anesth Analg (2009) 0.80
Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int (2016) 0.78
Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study. Adv Chronic Kidney Dis (2008) 0.78
The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis (2015) 0.78
Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis. Am J Nephrol (2013) 0.77
Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrol (2010) 0.77
Association of pre-transplant blood pressure with post-transplant outcomes. Clin Transplant (2013) 0.76
Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol (2013) 0.76
Clinical outcomes in secondary hyperparathyroidism and the potential role of calcimimetics. NDT Plus (2008) 0.76
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. Sci Rep (2015) 0.75
De-stiffening drug therapy and blood pressure control. Integr Blood Press Control (2010) 0.75
Assessment and reduction of fluid overload using a body composition monitor. NDT Plus (2009) 0.75
Renocardiac syndromes: physiopathology and treatment stratagems. Can J Kidney Health Dis (2015) 0.75
Retrospective angiographic study to determine the effect of atherosclerotic stenoses of upstream arteries on the degree of atherosclerosis in distal vascular territories. BMJ Open (2016) 0.75
Increased preoperative pulse pressure predicts procedural complications and mortality in patients who undergo tibial interventions for critical limb ischemia. J Vasc Surg (2015) 0.75
Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients. Clin J Am Soc Nephrol (2015) 0.75
Post-exercise pulse pressure is a better predictor of executive function than pre-exercise pulse pressure in cognitively normal older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2015) 0.75
Effect of inflammation on the relationship of pulse pressure and mortality in haemodialysis. Nephron Extra (2012) 0.75
Mineral metabolism and vascular disease in patients with end-stage renal failure. JAMA (2002) 0.75
Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension (2017) 0.75
Systolic Blood Pressure Trajectory, Frailty and All-Cause Mortality Over 80 Years of Age. Cohort Study Using Electronic Health Records. Circulation (2017) 0.75
Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality. Am J Kidney Dis (2017) 0.75
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Procedural volume as a marker of quality for CABG surgery. JAMA (2004) 3.70
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 3.70
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2005) 3.63
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol (2009) 3.40
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int (2008) 3.34
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg (2002) 2.91
The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg (2003) 2.86
Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge. Kidney Int (2009) 2.73
Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis (2003) 2.70
Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg (2007) 2.60
Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg (2007) 2.59
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation (2006) 2.51
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis (2006) 2.22
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 2.18
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol (2009) 1.95
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol (2005) 1.94
The association between mental health, physical function, and hemodialysis mortality. Kidney Int (2003) 1.93
Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol (2002) 1.92
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation (2002) 1.88
Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics (2003) 1.86
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis (2010) 1.84
Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int (2010) 1.83
Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med (2002) 1.83
Balancing Fistula First with Catheters Last. Am J Kidney Dis (2007) 1.83
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol (2010) 1.82
National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol (2002) 1.79
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. Am J Kidney Dis (2005) 1.75
The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis (2008) 1.74
Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction. Arch Intern Med (2010) 1.73
Interpreting statistics in medical literature: a vade mecum for surgeons. J Am Coll Surg (2004) 1.70
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2005) 1.69
Digoxin associates with mortality in ESRD. J Am Soc Nephrol (2010) 1.66
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2003) 1.60
Medical costs of abnormal serum sodium levels. J Am Soc Nephrol (2008) 1.56
The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int (2003) 1.55
Association between achievement of hemodialysis quality-of-care indicators and quality-of-life scores. Am J Kidney Dis (2009) 1.55
Is early too early? Effect of shorter stays after bypass surgery. Ann Thorac Surg (2007) 1.54
Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet (2005) 1.54
Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis (2008) 1.52
Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int (2002) 1.51
Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol (2009) 1.50
Multifaceted intervention to promote beta-blocker use in heart failure. Am Heart J (2006) 1.48
Economic effects of beta-blocker therapy in patients with heart failure. Am J Med (2004) 1.46
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS (2008) 1.46
Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. Clin J Am Soc Nephrol (2010) 1.44
Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant? Nephrology (Carlton) (2012) 1.42
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol (2003) 1.42
Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int (2005) 1.40
Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis (2009) 1.39
A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin J Am Soc Nephrol (2009) 1.38
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol (2005) 1.38
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol (2005) 1.37
Does calcium kill ESRD patients--the skeptic's perspective. Nephrol Dial Transplant (2002) 1.37
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis (2007) 1.32
Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant (2003) 1.31
Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg (2006) 1.31
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol (2008) 1.30
Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis (2006) 1.28
Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am J Kidney Dis (2005) 1.27
Change in vascular access and mortality in maintenance hemodialysis patients. Am J Kidney Dis (2009) 1.25
Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med (2006) 1.24
Predicting risk-adjusted mortality for CABG surgery: logistic versus hierarchical logistic models. Med Care (2005) 1.20
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr (2003) 1.20
The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.15
Exploring the behavior of hospital composite performance measures: an example from coronary artery bypass surgery. Circulation (2007) 1.15
Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials (2009) 1.13
Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients. J Acquir Immune Defic Syndr (2006) 1.12
White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant (2003) 1.12
Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease. Circulation (2005) 1.10